We evaluated copy number alterations (CNA), DNA methylation, histone modifications, and MELK expression using publicly available databases, as well as conducting FISH, RNA-Seq, qRT-PCR, and IHC assays in breast cancer cell lines and tumors tissues. The gene discussed is MELK; the disease is breast carcinoma.